Roche announced today that the US Food and Drug Administration (FDA) has approved ENSPRYNG™ (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with anti-aquaporin-4 (AQP4) antibody positive neuromyelitis optica spectrum disorder (NMOSD). Read more
RYE BROOK, N.Y. –(BUSINESS WIRE)–Aug. 13, 2020– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a third quarter dividend of $0.26 per share payable on September 24, 2020 to shareholders of record as of August 27, 2020 . Xylem is a leading global water technology company committed Read more
The VERDER Group has acquired the German company Porotec GmbH, thus further expanding its particle characterization business. Porotec develops and sells particle and porosity measurement instruments and is located near Frankfurt am Main, Germany. Porotec operates successfully as a dealer for Microtrac MRB, a company under the roof of the Verder Scientific Division also specialized... Read more
Venlo, The Netherlands, August 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will continue to execute its successful growth strategy aiming to create significant value for shareholders and other stakeholders after the voluntary public takeover offer by Thermo Fisher Scientific, Inc. (NYSE: TMO) did not achieve the minimum 66.67% acceptance threshold... Read more
Thermo Fisher Scientific Supports COVID-19 Testing at Historically Black Colleges and Universities Seeking to Provide a Safe Return to Campus WALTHAM, Mass., Aug. 12, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, has committed to supporting the efforts of historically black colleges and universities (HBCUs) in the U.S. to... Read more
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of 19,430,000 shares of its common stock at a price to the public of $4.47 per share. The offering is expected to... Read more
MINNEAPOLIS, Aug. 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds to the SARS-CoV-2 spike receptor binding domain (RBD) and blocks the virus from binding to its host receptor, ACE-2, inhibiting viral infection . The SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody is the... Read more
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional... Read more
Madison, WI USA. (August 11, 2020) Promega Corporation today announced the launch of its new serological antibody test for COVID-19 to detect the presence of antibodies against the SARS-CoV-2 virus. A positive result may indicate whether an individual has been exposed to, and mounted an immune response to, the virus. Promega has submitted an application to the US... Read more